Kristian M Hargadon (K M Hargadon)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Transcription Factor

Cancer Stem Cells

Top Venues

Cellular and molecular life sciences : CMLS

Technology in cancer research & treatment

Journal of cancer education : the official journal of the American Association for Cancer Education

Clinical and translational discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Kristian M Hargadon
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer. Cellular and molecular life sciences : CMLS 80 (2) (2023)
Kristian M Hargadon, Elijah W Strong
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Technology in cancer research & treatment 22 (2023)
Kristian M Hargadon, Elijah W Strong
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Technology in cancer research & treatment 22 (2023)
Kristian M Hargadon
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer. Cellular and molecular life sciences : CMLS 80 (2) (2023)
Kristian M Hargadon
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer. Cellular and molecular life sciences : CMLS 80 (2) (2023)
Kristian M Hargadon, Elijah W Strong
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Technology in cancer research & treatment 22 (2023)
Kristian M Hargadon, Elijah W Strong
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer. Technology in cancer research & treatment 22 (2023)
Kristian M Hargadon
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer. Cellular and molecular life sciences : CMLS 80 (2) (2023)
Kristian M Hargadon
A Bioinformatic Approach to Enhance Undergraduate Student Understanding of the Cancer-Immunity Cycle. Journal of cancer education : the official journal of the American Association for Cancer Education (2022)
Kristian M Hargadon, Travis B Goodloe, Nathaniel D Lloyd
Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective. Cancer metastasis reviews (2022)
Kristian M Hargadon
A call for discovery: Re-envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0-The COVID-19 Genome Atlas. Clinical and translational discovery 1 (1) (2021)
Kristian M Hargadon
Using The Cancer Genome Atlas as a Tool to Improve Undergraduate Student Understanding of Cancer Genetics and the Hallmarks of Cancer Progression. Journal of cancer education : the official journal of the American Association for Cancer Education (2021)
Kristian M Hargadon
The role of interferons in melanoma resistance to immune checkpoint blockade: mechanisms of escape and therapeutic implications. The British journal of dermatology (2021)